Evidence-tier compound research
Nootpedia
738 compounds — peptides, nootropics, supplements, stimulants, AAS/SARMs, hormones — each verdict-tier graded with confidence ratings and citations. A thorough intake produces compound rankings tailored to your profile, including niche picks. Cited AI chat over everything.
Featured today
For cognitive performance
Citicoline (CDP-Choline)
Supplement · Capsule
Already in this user's V stack daily stack at 500 mg Cognizin. Best-evidenced and cleanest-safety-profile chronic choline donor for a 20yo brain-priority MMA athlete with subconcussive impact exposure — A-tier replicated trials in healthy adults (attention, working memory, processing speed) plus a large stroke-recovery evidence base, no Korean-style cardiovascular signal, and the cytidine-uridine bonus citicoline uniquely delivers makes it the ideal chronic baseline cholinergic substrate. Verdict would only change if 23andMe shows something unexpected or if a major safety signal emerges.
N-Acetyl-Cysteine (NAC)
Supplement · Powder
Already in this user's V stack stack at 1200 mg/day (Swanson NAC, 2 caps). Massive A-tier evidence base — FDA-approved indication for paracetamol overdose, A-tier psychiatric (OCD, BFRB/trichotillomania), B-tier addiction + glutamate-toxicity rationale. Cheap, daily-safe, BBB-penetrant. For an MMA athlete with daily subconcussive impact, the glutamate-modulation + glutathione-precursor combination is mechanistically near-perfect — no other single supplement covers both lanes as well. Verdict would only weaken if a credible chronic-toxicity signal emerged at 1200-2400 mg/day (none currently exists after 30+ years of clinical use).
L-Theanine
Supplement · Powder
A-tier evidence for cleaner cognition when paired with caffeine; A-tier subjective sleep onset support; B-tier acute anxiolytic. Cheap, daily-safe, minimal tolerance, stack-clean with everything in V4. Already in V4 at Suntheanine 200 mg/day. Verdict would only change if a credible chronic-toxicity signal emerged (none does) or if the 2025 sleep meta-analysis "subjective-only, not objective" finding hardens into "placebo-equivalent on PSG" — at which point it stays A-tier for caffeine pairing but becomes B-tier (not A) for sleep onset.
By profile
Find your archetype
Young Cognitive
Template20-30, brain priority, knowledge worker / founder
Older Decline
Template50+, cognitive prevention, longevity protocols
Strength Athlete
TemplatePowerlifting, hypertrophy, AAS-curious
Anxiety-Prone
TemplateTrait anxiety, low sympathetic-load stack design
Recovery-Focused
TemplatePost-injury, post-op, post-viral peptide-heavy stacks
Executive Stress
Template35-50, sustained cognitive output, beginning drift
Your profile
TemplateBuild a profile to get personalized rankings — anonymous, stays on this device by default
By verdict
The verdict ladder
Highest-confidence picks the editor uses daily
Top recommended adds — replicated evidence
High-quality data — pending integration
Works for specific subgoals; opt-in
Promising but immature data; track quarterly
Not the right time (cost, risk, redundancy)
Risk:benefit fails on current evidence
Outside the scope of this corpus
Verdict pending classification
By class